BSE filing, BSE: 544231. Summary written from the filing by ALFA Finder's alert engine.
Broach Lifecare Hospital Ltd: key numbers
- Share price
- ₹12.70
- Market cap
- ₹7.71 Cr
- Revenue (annual)
- ₹5.99 Cr
- Net profit (annual)
- ₹0.09 Cr
- P/E (TTM)
- 88.8×Sector 34.0×
- Promoter holding
- 63.76%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Broach Lifecare Hospital Ltd
All →Broach Lifecare Hospital Other Announcement
Broach Lifecare Hospital Ltd has submitted its quarterly shareholding pattern as per Regulation 31(1)(b) for the period ending September 30, 2026.
Broach Lifecare Hospital Business Update
Broach Lifecare Hospital has secured empanelment with ONGC and ESIC. Additionally, it expanded PMJAY services and completed its NABH accreditation inspection.
- dialysis unit
- 5.0 beds
Broach Lifecare Hospital Management Change
Broach Lifecare Hospital Limited has appointed M/s. Rahul S Mithaiwala & Co. as the company's Secretarial Auditor effective September 30, 2026.
Broach Lifecare Hospital Other Announcement
Broach Lifecare Hospital Limited announced the appointment of M/s. Rahul Mithaiwala & Co. as the company's Secretarial Auditor for a five-year term.
Broach Lifecare Hospital Annual General Meeting
Broach Lifecare Hospital Ltd held its 3rd Annual General Meeting on September 30, 2026, through video conferencing to transact ordinary and special business.
Broach Lifecare Hospital Management Change
Broach Lifecare Hospital Ltd submitted the CFO's resignation letter following a BSE query, addressing an inadvertent omission from its previous disclosure regarding the management change.
Other board meeting date announcements
All →Jetking Infotrain Board Meeting Date
Jetking Infotrain has scheduled a board meeting on November 4, 2026 to consider unaudited quarterly and half-year results. The trading window remains closed until 48 hours after the results announcement.
Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Aelea Commodities Board Meeting Date
Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.
R Systems International Board Meeting Date
R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.
Onida Electronics Board Meeting Date
Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.
Platinum Industries Board Meeting Date
Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.